Evidence map›Paper›PMID 33516173›Full record

Observational studyBMC infectious diseases2021

Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.

Marta Ruiz-Algueró, Victoria Hernando, Henar Marcos, Gonzalo Gutiérrez, Maria Jesus Pérez-Elías, Juan Carlos López-Bernaldo de Quirós, Federico Pulido, Miguel Górgolas, Jesus Sanz, Ines Suarez-García and 17 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 19 institutions in 1 country.

Marta Ruiz-AlgueróUnidad de vigilancia de VIH, ITS y hepatitis, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, C/ Monforte de Lemos, 5, 28029, Madrid, Spain.
Victoria HernandoUnidad de vigilancia de VIH, ITS y hepatitis, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, C/ Monforte de Lemos, 5, 28029, Madrid, Spain.
Henar MarcosServicio de Vigilancia Epidemiológica y Enfermedades Transmisibles, DG de Salud Pública, Consejería de Sanidad, Valladolid, Castilla y León, Spain.
Gonzalo GutiérrezServicio de Epidemiología, DG de Salud Pública, Consejería de Sanidad, Toledo, Castilla-La Mancha, Spain.
Maria Jesus Pérez-ElíasServicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Juan Carlos López-Bernaldo de QuirósServicio de Enfermedades Infecciosas, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Federico PulidoUnidad VIH, Hospital Universitario 12 de Octubre. imas12.UCM, Madrid, Spain.
Miguel GórgolasUnidad de Enfermedades Infecciosas y VIH, Fundación Jimenez Díaz, Madrid, Spain.
Jesus SanzUnidad de Enfermedades Infecciosas, Hospital Universitario de La Princesa, Madrid, Spain.
Ines Suarez-GarcíaGrupo de enfermedades infecciosas, Servicio de Medicina Interna, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
Maria Teresa FernandezServicio de Medicina Interna, Hospital del Sureste, Arganda del Rey, Madrid, Spain.
Juan Emilio LosaUnidad de Enfermedades Infecciosas, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain.
Jose Luis PérezServicio de Medicina Interna, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain.
Maria Oliva LadreroCoordinación de VIH/sida, Servicio de Promoción de la Salud y Prevención de la Enfermedad, D.G. de Salud Pública, Zaragoza, Aragón, Spain.
Miguel Ángel PrietoServicio de Evaluación de la Salud y Programas, DG de Salud Pública, Consejería de Sanidad, Oviedo, Asturias, Spain.
Gustavo GonzálezOficina de Coordinación VIH de Extremadura, Servicio de Participación Comunitaria en Salud, DG de Salud Pública, Servicio Extremeño de Salud, Mérida, Extremadura, Spain.
Ana IzquierdoServicio de Epidemiología y Promoción de la Salud, DG de Salud Pública, Servicio Canario de la Salud, Santa Cruz de Tenerife, Canarias, Spain.
Luis Javier ViloriaSección de Vigilancia Epidemiológica, DG de Salud Pública, Santander, Cantabria, Spain.
Irene LópezServicio de Prevención y Epidemiología del Plan sobre sida, Consejería de Sanidad y Consumo, Ceuta, Spain.
Eva MartínezSección de Vigilancia Epidemiológica y Control de Enfermedades Transmisibles, DG de Salud Pública y Consumo, Logroño, La Rioja, Spain.
Daniel CastrillejoServicio de Epidemiología, DG de Sanidad y Consumo, Consejería de Bienestar Social y Sanidad, Melilla, Spain.
Rosa ArangurenCoordinación Autonómica de Drogas y de la Estrategia de Sida, DG de Salut Pública i Consum, Conselleria de Salut, Família i Bienestar Social, Palma de Mallorca, Baleares, Spain.
Maria Antonia BelmonteServicio de Promoción y Educación para la Salud, Dirección General de Salud Pública y Adicciones, Consejería de Salud, Murcia, Región de Murcia, Spain.
I V Aranda-GarcíaServicio Promoción de la Salud y Prevención en la Etapas de la Vida, Dirección General de Salud Pública y Adicciones, Conselleria de Sanitat Universal i Salut Pública, Valencia, Comunidad Valenciana, Spain.
Antonio ArraizaProgramas de Salud, Direccion General, Osakidetza, San Sebastian, País Vasco, Spain.
Asuncion DiazUnidad de vigilancia de VIH, ITS y hepatitis, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, C/ Monforte de Lemos, 5, 28029, Madrid, Spain. adiaz@isciii.es.ORCID http://orcid.org/0000-0002-8309-4270
Hospital Survey Study Group
Instituto de Salud Carlos III · ESConsejería de Educación de la Junta de Castilla y León · ESConsejería de Salud y Consumo · ESConselleria de Sanitat Universal i Salut Pública · ESGobierno de La Rioja · ESGovernment of Extremadura · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario 12 De Octubre · ESHospital Universitario de La Princesa · ESHospital Universitario del Sureste · ESHospital Universitario Fundación Alcorcón · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Infanta Cristina · ESHospital Universitario Infanta Sofía · ESHospital Universitario Ramón y Cajal · ESProspektiker (Spain) · ESServicio Canario de la Salud · ESServicio Cántabro de Salud · ESServicio Murciano de Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIV infection has become a chronic disease and well-being of people living with HIV (PLHIV) is now of particular concern. The objectives of this paper were to describe self-rated health among PLHIV, on ART and on ART virally suppressed and to analyse its determinants.

methodsData were obtained from a second-generation surveillance system based on a cross-sectional one-day survey in public hospitals. Epidemiological and clinical data were collected among HIV-infected inpatients and outpatients receiving HIV-related care the day of the survey in 86 hospitals in 2019. Self-rated health was measured using a question included in the National Health Survey: "In the last 12 months, how would you rate your health status?" an ordinal variable with five categories (very good, good, moderate, bad and very bad). For the analysis, these responses were dichotomized into two categories: 1 = very good/good and 0 = moderate, bad or very bad health status. Factors associated with very good/good self-rated health were estimated using logistic regression.

resultsOf 800 PLHIV, 67.5% perceived their health as very good/good, 68.4% among PLHIV on ART and 71.7% of those virally suppressed. Having university education (adjusted odds ratio (aOR):2.1), being unemployed (aOR:0.3) or retired (aOR:0.2), ever being diagnosed of AIDS (aOR:0.6), comorbidities (aOR:0.3), less than 2 year since HIV diagnosis (aOR:0.3) and not receiving ART (aOR:0.3) were associated with good self-rated health. Moreover, among PLHIV on ART, viral load less than 200 copies (aOR:3.2) were related to better perceived health. Bad adherence was inversely associated with good self-rated health among PLHIV on ART (aOR:0.5) and of those virally suppressed (aOR:0.4).

conclusionsNearly seven in 10 PLHIV in Spain considered their health status as very good/good, being higher among virally suppressed PLHIV. Both demographic and clinical determinants affect quality of life.

Indexed as

Diagnostic Self EvaluationHealth StatusAdultAnti-Retroviral AgentsCross-Sectional StudiesFemaleHIV InfectionsHumansMaleMiddle AgedQuality of LifeSpainSurveys and QuestionnairesViral LoadYoung AdultAnti-Retroviral AgentsFourth 90Health quality of lifePeople living with HIVSelf-rated healthSpain

Identifiers

PMID33516173
PMCPMC7847002
OpenAlexW3129142347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.